Mechanistically, the loss of Trx-1 function resulted in the activation of the ERK pathway, a well-known player in concentric heart hypertrophy and a protector against pro-apoptotic stimuli [74]. The gene discussed is KMT2A; the disease is cardiac hypertrophy.